Published in J Immunol on February 01, 2007
Adipokines in inflammation and metabolic disease. Nat Rev Immunol (2011) 8.92
Nampt/PBEF/Visfatin regulates insulin secretion in beta cells as a systemic NAD biosynthetic enzyme. Cell Metab (2007) 4.16
Adipokines and insulin resistance. Mol Med (2008) 2.97
Inflammatory mechanisms in the regulation of insulin resistance. Mol Med (2008) 2.71
Nampt: linking NAD biology, metabolism and cancer. Trends Endocrinol Metab (2008) 2.47
Kupffer cells in non-alcoholic fatty liver disease: the emerging view. J Hepatol (2009) 2.26
Inflammation, a link between obesity and cardiovascular disease. Mediators Inflamm (2010) 1.80
Molecular signatures of obstructive sleep apnea in adults: a review and perspective. Sleep (2009) 1.76
Current trends in inflammatory and immunomodulatory mediators in sepsis. J Leukoc Biol (2012) 1.52
Pharmacological inhibition of nicotinamide phosphoribosyltransferase/visfatin enzymatic activity identifies a new inflammatory pathway linked to NAD. PLoS One (2008) 1.48
Treatment with imatinib results in reduced IL-4-producing T cells, but increased CD4(+) T cells in the broncho-alveolar lavage of patients with systemic sclerosis. Clin Immunol (2011) 1.39
Essential role of pre-B-cell colony enhancing factor in ventilator-induced lung injury. Am J Respir Crit Care Med (2008) 1.38
Biochemistry of adipose tissue: an endocrine organ. Arch Med Sci (2013) 1.36
Extracellular Nampt promotes macrophage survival via a nonenzymatic interleukin-6/STAT3 signaling mechanism. J Biol Chem (2008) 1.29
Adipose inflammation, insulin resistance, and cardiovascular disease. JPEN J Parenter Enteral Nutr (2008) 1.25
Leptin, resistin and visfatin: the missing link between endocrine metabolic disorders and immunity. Eur J Med Res (2013) 1.19
Sleep duration and circulating adipokine levels. Sleep (2011) 1.18
Sleep-disordered breathing and pregnancy: potential mechanisms and evidence for maternal and fetal morbidity. Curr Opin Pulm Med (2010) 1.16
Sleep duration, cardiovascular disease, and proinflammatory biomarkers. Nat Sci Sleep (2013) 1.13
Fat: a matter of disturbance for the immune system. World J Gastroenterol (2010) 1.13
Therapeutic potential of SIRT1 and NAMPT-mediated NAD biosynthesis in type 2 diabetes. Front Biosci (Landmark Ed) (2009) 1.12
Differential intra-abdominal adipose tissue profiling in obese, insulin-resistant women. Obes Surg (2009) 1.10
Adipocytokines in systemic lupus erythematosus: relationship to inflammation, insulin resistance and coronary atherosclerosis. Lupus (2009) 1.10
The role of adipokines in connective tissue diseases. Eur J Nutr (2012) 1.09
Peripheral blood gene expression patterns discriminate among chronic inflammatory diseases and healthy controls and identify novel targets. BMC Med Genomics (2010) 1.09
Oxidative stress in obesity: a critical component in human diseases. Int J Mol Sci (2014) 1.08
Visfatin/Nampt: an adipokine with cardiovascular impact. Mediators Inflamm (2013) 1.03
Increased synovial fluid visfatin is positively linked to cartilage degradation biomarkers in osteoarthritis. Rheumatol Int (2011) 1.02
Adipokines and osteoarthritis: novel molecules involved in the pathogenesis and progression of disease. Arthritis (2011) 0.98
Adipokines: Biomarkers for osteoarthritis? World J Orthop (2014) 0.98
Nicotinamide phosphoribosyltransferase/visfatin does not catalyze nicotinamide mononucleotide formation in blood plasma. PLoS One (2011) 0.97
Nicotinamide phosphoribosyltransferase in malignancy: a review. Genes Cancer (2013) 0.97
Potential role of leptin, adiponectin and three novel adipokines--visfatin, chemerin and vaspin--in chronic hepatitis. Mol Med (2011) 0.95
Role of adipokines in atherosclerosis: interferences with cardiovascular complications in rheumatic diseases. Mediators Inflamm (2012) 0.95
Clinical implications of adipocytokines and newly emerging metabolic factors with relation to insulin resistance and cardiovascular health. Front Endocrinol (Lausanne) (2013) 0.94
Regulation of visfatin by microbial and biomechanical signals in PDL cells. Clin Oral Investig (2013) 0.93
Specific metabolic biomarkers as risk and prognostic factors in colorectal cancer. World J Gastroenterol (2014) 0.93
Visfatin in human pregnancy: maternal gestational diabetes vis-à-vis neonatal birthweight. J Perinat Med (2009) 0.92
Value of adipokines in predicting the severity of acute pancreatitis: comprehensive review. World J Gastroenterol (2012) 0.92
Endothelial NLRP3 inflammasome activation and enhanced neointima formation in mice by adipokine visfatin. Am J Pathol (2014) 0.92
The effect of omega-3 on the serum visfatin concentration in patients with type II diabetes. J Res Med Sci (2011) 0.91
The NAMPT inhibitor FK866 reverts the damage in spinal cord injury. J Neuroinflammation (2012) 0.91
Pre-B cell colony enhancing factor (PBEF), a cytokine with multiple physiological functions. Cytokine Growth Factor Rev (2013) 0.90
Adipocytokines in atherothrombosis: focus on platelets and vascular smooth muscle cells. Mediators Inflamm (2010) 0.90
Inflammatory markers and bariatric surgery: a meta-analysis. Inflamm Res (2012) 0.90
Expression and function of visfatin (Nampt), an adipokine-enzyme involved in inflammatory pathways of osteoarthritis. Arthritis Res Ther (2014) 0.90
Emerging role of adipokines as mediators in atherosclerosis. World J Cardiol (2010) 0.89
Immunomodulatory effects of sex hormones: requirements for pregnancy and relevance in melanoma. Mayo Clin Proc (2014) 0.89
Adipokines as drug targets in diabetes and underlying disturbances. J Diabetes Res (2015) 0.89
Adipokines NUCB2/nesfatin-1 and visfatin as novel inflammatory factors in chronic obstructive pulmonary disease. Mediators Inflamm (2014) 0.87
Effects of age on the synergistic interactions between lipopolysaccharide and mechanical ventilation in mice. Am J Respir Cell Mol Biol (2009) 0.87
Lacritin and the tear proteome as natural replacement therapy for dry eye. Exp Eye Res (2013) 0.87
Role of adipokines signaling in the modulation of T cells function. Front Immunol (2013) 0.87
Visfatin is induced by peroxisome proliferator-activated receptor gamma in human macrophages. FEBS J (2010) 0.87
Adipokines, biomarkers of endothelial activation, and metabolic syndrome in patients with ankylosing spondylitis. Biomed Res Int (2014) 0.86
Association between novel adipocytokines adiponectin, vaspin, visfatin, and thyroid: An experimental and clinical update. Endocr Connect (2013) 0.86
Proinflammatory actions of visfatin/nicotinamide phosphoribosyltransferase (Nampt) involve regulation of insulin signaling pathway and Nampt enzymatic activity. J Biol Chem (2012) 0.86
Maternal visfatin concentration in normal pregnancy. J Perinat Med (2009) 0.86
Nicotinamide phosphoribosyltransferase promotes epithelial-to-mesenchymal transition as a soluble factor independent of its enzymatic activity. J Biol Chem (2014) 0.86
Secret talk between adipose tissue and central nervous system via secreted factors-an emerging frontier in the neurodegenerative research. J Neuroinflammation (2016) 0.86
Controlled meal frequency without caloric restriction alters peripheral blood mononuclear cell cytokine production. J Inflamm (Lond) (2011) 0.85
Visfatin induces oxidative stress in differentiated C2C12 myotubes in an Akt- and MAPK-independent, NFkB-dependent manner. Pflugers Arch (2009) 0.85
Visfatin levels and intima-media thicknesses in rheumatic diseases. Clin Rheumatol (2010) 0.85
Serum adipokines in inflammatory bowel disease. World J Gastroenterol (2014) 0.84
Obesity-related insulin resistance: implications for the surgical patient. Int J Obes (Lond) (2015) 0.84
Mice deficient in Sfrp1 exhibit increased adiposity, dysregulated glucose metabolism, and enhanced macrophage infiltration. PLoS One (2013) 0.84
Visfatin/pre-B-cell colony-enhancing factor (PBEF), a proinflammatory and cell motility-changing factor in rheumatoid arthritis. J Biol Chem (2012) 0.84
Adipokines correlate with pain in lower limb osteoarthritis: different associations in hip and knee. Int Orthop (2014) 0.83
Adipokines in bone disease. Nat Rev Rheumatol (2016) 0.83
Beijing ambient particle exposure accelerates atherosclerosis in ApoE knockout mice by upregulating visfatin expression. Cell Stress Chaperones (2014) 0.83
Elevated plasma level of visfatin/pre-b cell colony-enhancing factor in male oral squamous cell carcinoma patients. Med Oral Patol Oral Cir Bucal (2013) 0.82
Evaluation of adipokines: apelin, visfatin, and resistin in children with atopic dermatitis. Mediators Inflamm (2013) 0.82
Lymphocytes and macrophages in adipose tissue in obesity: markers or makers of subclinical inflammation? Protoplasma (2017) 0.81
Sepsis-Induced Adipokine Change with regard to Insulin Resistance. Int J Inflam (2012) 0.81
[Adipokine update - new molecules, new functions]. Wien Med Wochenschr (2010) 0.81
Hypercholesterolemia induces adipose dysfunction in conditions of obesity and nonobesity. Adv Nutr (2014) 0.81
Relationship of circulating adipokines to body composition in pregnant women. Adipocyte (2014) 0.80
Visfatin is regulated by rosiglitazone in type 2 diabetes mellitus and influenced by NFκB and JNK in human abdominal subcutaneous adipocytes. PLoS One (2011) 0.80
Nicotinamide phosphoribosyltransferase can affect metastatic activity and cell adhesive functions by regulating integrins in breast cancer. DNA Repair (Amst) (2014) 0.80
Obesity as a risk and severity factor in rheumatic diseases (autoimmune chronic inflammatory diseases). Front Immunol (2014) 0.80
The interplay between inflammation and metabolism in rheumatoid arthritis. Cell Death Dis (2015) 0.80
Inflammatory and Other Biomarkers: Role in Pathophysiology and Prediction of Gestational Diabetes Mellitus. Int J Mol Sci (2015) 0.79
[Adipocytokines as driving forces in rheumatoid arthritis]. Z Rheumatol (2007) 0.79
Could alterations in maternal plasma visfatin concentration participate in the phenotype definition of preeclampsia and SGA? J Matern Fetal Neonatal Med (2010) 0.79
Human NK cell subset functions are differentially affected by adipokines. PLoS One (2013) 0.78
Conjugated linoleic acid modulation of risk factors associated with atherosclerosis. Nutr Metab (Lond) (2008) 0.78
Adipokines as potential biomarkers in rheumatoid arthritis. Mediators Inflamm (2014) 0.78
Visfatin levels in patients with severe pneumonia. World J Emerg Med (2011) 0.78
Resistin and visfatin: are they valuable enough to be the differential diagnosis in familial Mediterranean fever with acute appendicitis? Clin Rheumatol (2011) 0.78
Rheumatic diseases and obesity: adipocytokines as potential comorbidity biomarkers for cardiovascular diseases. Mediators Inflamm (2013) 0.78
Bacterial translocation - impact on the adipocyte compartment. Front Immunol (2014) 0.78
Adipokine gene expression in peripheral blood of adult and juvenile dermatomyositis patients and their relation to clinical parameters and disease activity measures. J Inflamm (Lond) (2015) 0.78
Pre-B-cell colony-enhancing factor and its clinical correlates with acute lung injury and sepsis. Chest (2011) 0.78
Circulating Visfatin in Hypothyroidism Is Associated with Free Thyroid Hormones and Antithyroperoxidase Antibodies. Int J Endocrinol (2016) 0.78
Obesity: systemic and pulmonary complications, biochemical abnormalities, and impairment of lung function. Multidiscip Respir Med (2016) 0.78
Association of serum microRNA-21 levels with Visfatin, inflammation, and acute coronary syndromes. Heart Vessels (2016) 0.78
Interlinking Periodontitis and Type 2 Diabetes Mellitus by Assessment of Crevicular Visfatin Levels in Health and in Disease Before and After Initial Periodontal Therapy. J Clin Diagn Res (2016) 0.77
Increased expression of visfatin in monocytes and macrophages in male acute myocardial infarction patients. Mediators Inflamm (2012) 0.77
XBP1 links ER stress to intestinal inflammation and confers genetic risk for human inflammatory bowel disease. Cell (2008) 8.43
The second European evidence-based Consensus on the diagnosis and management of Crohn's disease: Special situations. J Crohns Colitis (2009) 3.66
Adiponectin induces the anti-inflammatory cytokines IL-10 and IL-1RA in human leukocytes. Biochem Biophys Res Commun (2004) 3.21
Progressive fibrosis in nonalcoholic steatohepatitis: association with altered regeneration and a ductular reaction. Gastroenterology (2007) 3.18
Gut microbiome, obesity, and metabolic dysfunction. J Clin Invest (2011) 2.93
Blockade of receptor activator of nuclear factor-κB (RANKL) signaling improves hepatic insulin resistance and prevents development of diabetes mellitus. Nat Med (2013) 2.93
BH3-only proteins Puma and Bim are rate-limiting for gamma-radiation- and glucocorticoid-induced apoptosis of lymphoid cells in vivo. Blood (2005) 2.54
Autocrine formation of hepcidin induces iron retention in human monocytes. Blood (2007) 2.50
Regulation of iron homeostasis in anemia of chronic disease and iron deficiency anemia: diagnostic and therapeutic implications. Blood (2009) 2.41
p16INK4A is a robust in vivo biomarker of cellular aging in human skin. Aging Cell (2006) 2.34
Erythropoietin contrastingly affects bacterial infection and experimental colitis by inhibiting nuclear factor-κB-inducible immune pathways. Immunity (2011) 2.20
Development of the Crohn's disease digestive damage score, the Lémann score. Inflamm Bowel Dis (2010) 2.20
Neonatal Fc receptor for IgG regulates mucosal immune responses to luminal bacteria. J Clin Invest (2006) 2.16
Paneth cells as a site of origin for intestinal inflammation. Nature (2013) 2.09
Regurgitation of bile acids from leaky bile ducts causes sclerosing cholangitis in Mdr2 (Abcb4) knockout mice. Gastroenterology (2004) 2.02
CD4+CD25+ regulatory T cells inhibit experimental anti-glomerular basement membrane glomerulonephritis in mice. J Am Soc Nephrol (2005) 1.83
Eotaxin-3 in Churg-Strauss syndrome: a clinical and immunogenetic study. Rheumatology (Oxford) (2011) 1.74
Ca2+ channel blockers reverse iron overload by a new mechanism via divalent metal transporter-1. Nat Med (2007) 1.73
Second European evidence-based consensus on the diagnosis and management of ulcerative colitis part 3: special situations. J Crohns Colitis (2012) 1.71
ER stress transcription factor Xbp1 suppresses intestinal tumorigenesis and directs intestinal stem cells. J Exp Med (2013) 1.70
Genome-wide association analysis in primary sclerosing cholangitis. Gastroenterology (2009) 1.69
The effect of zoledronic acid on the function and differentiation of myeloid cells. Haematologica (2006) 1.66
Pharmacologic inhibition of hepcidin expression reverses anemia of chronic inflammation in rats. Blood (2011) 1.63
Microsomal triglyceride transfer protein lipidation and control of CD1d on antigen-presenting cells. J Exp Med (2005) 1.57
Intestinal permeability--a new target for disease prevention and therapy. BMC Gastroenterol (2014) 1.52
The co-ordinated regulation of iron homeostasis in murine macrophages limits the availability of iron for intracellular Salmonella typhimurium. Cell Microbiol (2007) 1.51
Hepatitis B virus-induced lipid alterations contribute to natural killer T cell-dependent protective immunity. Nat Med (2012) 1.50
Increased expression of CCL20 in human inflammatory bowel disease. J Clin Immunol (2004) 1.50
Cd1d-dependent regulation of bacterial colonization in the intestine of mice. J Clin Invest (2009) 1.49
Clinical presentation of venous thromboembolism in inflammatory bowel disease. J Crohns Colitis (2012) 1.49
CD1d function is regulated by microsomal triglyceride transfer protein. Nat Med (2004) 1.49
Obesity and the microbiota. Gastroenterology (2009) 1.49
The arachidonic acid metabolome serves as a conserved regulator of cholesterol metabolism. Cell Metab (2014) 1.47
Anti-tumor necrosis factor-alpha monoclonal antibody therapy in severe alcoholic hepatitis. J Hepatol (2003) 1.45
Recent advances in inflammatory bowel disease: mucosal immune cells in intestinal inflammation. Gut (2013) 1.44
Absence of functional Hfe protects mice from invasive Salmonella enterica serovar Typhimurium infection via induction of lipocalin-2. Blood (2009) 1.40
SHP1 phosphatase-dependent T cell inhibition by CEACAM1 adhesion molecule isoforms. Immunity (2006) 1.33
Anti-inflammatory effects of excessive weight loss: potent suppression of adipose interleukin 6 and tumour necrosis factor alpha expression. Gut (2010) 1.30
Crohn's disease: NOD2, autophagy and ER stress converge. Gut (2011) 1.27
Overexpression of indoleamine 2,3-dioxygenase in human inflammatory bowel disease. Clin Immunol (2004) 1.26
Pathways underlying iron accumulation in human nonalcoholic fatty liver disease. Am J Clin Nutr (2008) 1.25
Inflammatory bowel disease is a risk factor for recurrent venous thromboembolism. Gastroenterology (2010) 1.23
The kinase inhibitor imatinib mesylate inhibits TNF-{alpha} production in vitro and prevents TNF-dependent acute hepatic inflammation. Proc Natl Acad Sci U S A (2005) 1.23
Knockdown of PgP resensitizes leukemic cells to proteasome inhibitors. Biochem Biophys Res Commun (2007) 1.16
A role for low hepatic copper concentrations in nonalcoholic Fatty liver disease. Am J Gastroenterol (2010) 1.15
Peripheral infusion of rat bone marrow derived endothelial progenitor cells leads to homing in acute lung injury. Respir Res (2007) 1.14
Role of IL-10 for induction of anemia during inflammation. J Immunol (2002) 1.13
Treatment strategies in nonalcoholic fatty liver disease. Nat Clin Pract Gastroenterol Hepatol (2005) 1.13
Pathways for the regulation of interferon-gamma-inducible genes by iron in human monocytic cells. J Leukoc Biol (2003) 1.12
Atherosclerosis research from past to present--on the track of two pathologists with opposing views, Carl von Rokitansky and Rudolf Virchow. Virchows Arch (2006) 1.11
Pre-B cell colony enhancing factor/NAMPT/visfatin in inflammation and obesity-related disorders. Curr Pharm Des (2010) 1.08
Influence of visceral obesity and liver fat on vascular structure and function in obese subjects. Obesity (Silver Spring) (2009) 1.08
Inflammation, cytokines and insulin resistance: a clinical perspective. Arch Immunol Ther Exp (Warsz) (2013) 1.08
Up-regulation of the anti-inflammatory adipokine adiponectin in acute liver failure in mice. J Hepatol (2005) 1.07
Role for hedgehog pathway in regulating growth and function of invariant NKT cells. Eur J Immunol (2009) 1.07
Interferon-alpha controls IL-17 expression in vitro and in vivo. Immunobiology (2008) 1.07
Primary deficiency of microsomal triglyceride transfer protein in human abetalipoproteinemia is associated with loss of CD1 function. J Clin Invest (2010) 1.06
Adipose and liver expression of interleukin (IL)-1 family members in morbid obesity and effects of weight loss. Mol Med (2011) 1.06
Adiponectin and its receptors in patients with chronic hepatitis C. J Hepatol (2005) 1.04
Growth differentiation factor 15 in anaemia of chronic disease, iron deficiency anaemia and mixed type anaemia. Br J Haematol (2009) 1.03
Mechanisms of iron mediated regulation of the duodenal iron transporters divalent metal transporter 1 and ferroportin 1. Blood Cells Mol Dis (2003) 1.03
Differential regulation of apoptotic cell death in senescent human cells. Exp Gerontol (2004) 1.02
How to modulate inflammatory cytokines in liver diseases. Liver Int (2006) 1.02
Expansion and function of CD8+ T cells expressing Ly49 inhibitory receptors specific for MHC class I molecules. J Immunol (2004) 1.02
The RANKL/OPG system and bone mineral density in patients with chronic liver disease. J Hepatol (2005) 1.01
Mass spectrometry analysis of hepcidin peptides in experimental mouse models. PLoS One (2011) 1.00
Cross-linking of CD32 induces maturation of human monocyte-derived dendritic cells via NF-kappa B signaling pathway. J Immunol (2003) 1.00
Pathways for the regulation of hepcidin expression in anemia of chronic disease and iron deficiency anemia in vivo. Haematologica (2011) 0.99
Toll-like receptor 4-mediated endoplasmic reticulum stress in intestinal crypts induces necrotizing enterocolitis. J Biol Chem (2014) 0.98
In vivo analysis of the apoptosis-inducing effect of anti-endothelial cell antibodies in systemic sclerosis by the chorionallantoic membrane assay. Arthritis Rheum (2003) 0.98
Effects of weight loss induced by bariatric surgery on hepatic adipocytokine expression. J Hepatol (2009) 0.98
The immunomodulator FTY720 interferes with effector functions of human monocyte-derived dendritic cells. Eur J Immunol (2005) 0.98
Novel insights into autoimmune liver diseases provided by genome-wide association studies. J Autoimmun (2013) 0.96
Non-alcoholic steatohepatitis: a microbiota-driven disease. Trends Endocrinol Metab (2013) 0.96
Role of nuclear receptors and hepatocyte-enriched transcription factors for Ntcp repression in biliary obstruction in mouse liver. Am J Physiol Gastrointest Liver Physiol (2005) 0.96
Visceral adipose tissue attacks beyond the liver: esophagogastric junction as a new target. Gastroenterology (2010) 0.95
Role of NKT cells in the digestive system. III. Role of NKT cells in intestinal immunity. Am J Physiol Gastrointest Liver Physiol (2007) 0.95
Interleukin-32: a new proinflammatory cytokine involved in hepatitis C virus-related liver inflammation and fibrosis. Hepatology (2011) 0.95
Vedolizumab, a humanized mAb against the α4β7 integrin for the potential treatment of ulcerative colitis and Crohn's disease. Curr Opin Investig Drugs (2010) 0.95
Adipose tissue and liver expression of SIRT1, 3, and 6 increase after extensive weight loss in morbid obesity. J Hepatol (2013) 0.95
Inhibition of thrombin-induced signaling by resveratrol and quercetin: effects on adenosine nucleotide metabolism in endothelial cells and platelet-neutrophil interactions. Thromb Res (2004) 0.94
Interleukin-18 attracts plasmacytoid dendritic cells (DC2s) and promotes Th1 induction by DC2s through IL-18 receptor expression. Blood (2003) 0.93